Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing price July 28, 2021

ALXN Articles

The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia, Gilead Sciences, Goodyear, Philip Morris, Target and...
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...